| The Crohn's disease exclusion diet for induction and maintenance of remission in adults with mild-to-moderate Crohn's disease (CDED-AD): an open-label, pilot, randomised trial H Yanai, A Levine, A Hirsch, RS Boneh, U Kopylov, HB Eran, NA Cohen, ... The Lancet Gastroenterology & Hepatology 7 (1), 49-59, 2022 | 119 | 2022 |
| Use of faecal transplantation with a novel diet for mild to moderate active ulcerative colitis: the craft UC randomised controlled trial C Sarbagili Shabat, F Scaldaferri, E Zittan, A Hirsch, MC Mentella, ... Journal of Crohn's and Colitis 16 (3), 369-378, 2022 | 68 | 2022 |
| Vedolizumab is effective and safe in elderly inflammatory bowel disease patients: a binational, multicenter, retrospective cohort study NA Cohen, N Plevris, U Kopylov, A Grinman, B Ungar, H Yanai, ... United European Gastroenterology Journal 8 (9), 1076-1085, 2020 | 41 | 2020 |
| Surveillance of IBD using high definition colonoscopes does not miss adenocarcinoma in patients with low-grade dysplasia N Krugliak Cleveland, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Inflammatory bowel diseases 22 (3), 631-637, 2016 | 30 | 2016 |
| Dilemmas for guardians of advanced dementia patients regarding tube feeding E Gil, M Agmon, A Hirsch, M Ziv, A Zisberg Age and Ageing 47 (1), 138-143, 2018 | 22 | 2018 |
| Efficacy and Follow-up of Segmental or Subtotal Colectomy in Patients With Colitis-Associated Neoplasia. JE Ollech, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, SB Hanauer, ... Clinical Gastroenterology and Hepatology: the Official Clinical Practice …, 2018 | 19 | 2018 |
| Higher thioguanine nucleotide metabolite levels are associated with better long-term outcomes in patients with inflammatory bowel diseases AJ Yarur, B Gondal, A Hirsch, B Christensen, RD Cohen, DT Rubin Journal of Clinical Gastroenterology 52 (6), 537-544, 2018 | 18 | 2018 |
| Penetrating disease, narcotic use, and loop ostomy are associated with ostomy and IBD-related complications after ostomy surgery in Crohn’s disease patients A Hirsch, AJ Yarur, H Dezheng, D Rodriquez, NK Cleveland, T Ali, ... Journal of gastrointestinal surgery 19 (10), 1852-1861, 2015 | 17 | 2015 |
| Transcriptional Regulation of the Claudin-16 Gene by Mg2+Availability E Efrati, A Hirsch, O Kladnitsky, J Rozenfeld, M Kaplan, O Zinder, ... Cellular Physiology and Biochemistry 25 (6), 705-714, 2006 | 17 | 2006 |
| Vedolizumab in the treatment of Crohn’s disease D Tarabar, A Hirsch, DT Rubin Expert Review of Gastroenterology & Hepatology 10 (3), 283-290, 2016 | 15 | 2016 |
| Risk factors for malnutrition among IBD patients L Einav, A Hirsch, Y Ron, NA Cohen, S Lahav, J Kornblum, R Anbar, ... Nutrients 13 (11), 4098, 2021 | 13 | 2021 |
| Risk Factors for Clostridium difficile Isolation in Inflammatory Bowel Disease: A Prospective Study D Micic, A Yarur, A Gonsalves, VL Rao, S Broadaway, R Cohen, S Dalal, ... Digestive Diseases and Sciences 63, 1016-1024, 2018 | 13 | 2018 |
| Tu1350 vedolizumab in the treatment of IBD: the University of Chicago experience B Christensen, SR Goeppinger, RJ Colman, D Siddiqui, A Yarur, ... Gastroenterology 148 (4), S-866, 2015 | 13 | 2015 |
| Efficacy and Follow-up of Sub-Total Colectomy With Ileo-Rectal Anastomoses in Patients With Colitis-associated Neoplasia NK Cleveland, JE Ollech, RJ Colman, D Rodriquez, A Hirsch, RD Cohen, ... Clinical gastroenterology and hepatology: the official clinical practice …, 2019 | 12 | 2019 |
| Enteric infections complicating ulcerative colitis D Micic, A Hirsch, N Setia, DT Rubin Intestinal research 16 (3), 489, 2018 | 10 | 2018 |
| Successful treatment of ulcerative colitis with vedolizumab in a patient with an infliximab-associated psoriasiform rash A Hirsch, RJ Colman, GD Lang, DT Rubin ACG case reports journal 2 (4), 236-238, 2015 | 9 | 2015 |
| Curcumin-qingdai combination for patients with active ulcerative colitis: a randomized, double-blinded, placebo-controlled trial S Ben-Horin, N Salomon, G Karampekos, N Viazis, A Lahat, B Ungar, ... Clinical Gastroenterology and Hepatology 22 (2), 347-356. e6, 2024 | 8 | 2024 |
| Higher maintenance adalimumab trough levels are associated with achievement of advanced remission targets in patients with inflammatory bowel disease E Ritter, A Hirsch, NF Isakov, Y Ron, NA Cohen, N Maharshak Journal of Clinical Gastroenterology 55 (9), 810-814, 2021 | 8 | 2021 |
| Development and validation of processed foods questionnaire (PFQ) in adult inflammatory bowel diseases patients C Sarbagili-Shabat, S Zelber-Sagi, N Fliss Isakov, Y Ron, A Hirsch, ... European Journal of Clinical Nutrition 74 (12), 1653-1660, 2020 | 8 | 2020 |
| Real‐world experience with Curcumin–QingDai combination for patients with active ulcerative colitis: A retrospective multicentre cohort study H Yanai, N Salomon, A Lahat, B Ungar, R Eliakim, O Kriger‐Sharabi, ... Alimentary Pharmacology & Therapeutics 58 (2), 175-181, 2023 | 7 | 2023 |
